BRIEF-Targovax: Encouraging top line two-year survival data from TG01 clinical trial
* Announces encouraging top line two-year survival data from TG01 clinical trial in resected pancreatic cancer patients [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: trial, clinical, survival, two-year, patients, cancer, resected pancreatic, encouraging, Announces, Encouraging, BRIEF-Targovax
Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/aAEKFVLYvLU/idUSFWN1FN0FA